Dupree Financial Group LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 9,859 shares of the healthcare conglomerate's stock, valued at approximately $3,076,000.
Other large investors have also modified their holdings of the company. Brighton Jones LLC boosted its holdings in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its holdings in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after acquiring an additional 2,324 shares during the last quarter. GAMMA Investing LLC increased its stake in UnitedHealth Group by 7.4% during the first quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate's stock worth $8,295,000 after acquiring an additional 1,089 shares during the last quarter. Intact Investment Management Inc. lifted its stake in shares of UnitedHealth Group by 120.0% in the 1st quarter. Intact Investment Management Inc. now owns 2,200 shares of the healthcare conglomerate's stock valued at $1,152,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Live Oak Private Wealth LLC increased its position in UnitedHealth Group by 2.1% during the 1st quarter. Live Oak Private Wealth LLC now owns 25,306 shares of the healthcare conglomerate's stock worth $13,254,000 after purchasing an additional 515 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Trading Up 2.2%
UNH opened at $364.31 on Tuesday. The stock has a market capitalization of $329.95 billion, a PE ratio of 15.78, a P/E/G ratio of 2.31 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The firm's fifty day moving average price is $331.62 and its 200 day moving average price is $341.12.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter last year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.
Analyst Upgrades and Downgrades
Several research firms have issued reports on UNH. Mizuho boosted their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an "outperform" rating in a research note on Thursday, October 9th. Baird R W lowered UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Robert W. Baird reaffirmed an "underperform" rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Cantor Fitzgerald reissued an "overweight" rating and set a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Finally, Bank of America lifted their price objective on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a "neutral" rating in a research note on Wednesday, October 8th. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $385.13.
Read Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.